Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells
Simona Camorani(National Academies of Sciences, Engineering, and Medicine), Laura Cerchia(National Academies of Sciences, Engineering, and Medicine)
Cited by 67
Related Papers
Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers
|Scientific Reports|2017|93
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer
|Theranostics|2017|91
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors
|Journal of Experimental & Clinical Cancer Research|2021|82
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
|Journal of Experimental & Clinical Cancer Research|2020|70
Frontiers in Drug Design and Discovery
|Unknown|2006|49